3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Sleep Wake Disorders
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Obesity
1
Neoplasms
1
Motor Activity
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Castration-Resistant Prostate Cancer (CRPC)
1
Carcinoma, Renal Cell
1
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Cyclophosphamide
4
pembrolizumab
3
fludarabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
atezolizumab
2
anlotinib
2
Temozolomide
2
Irinotecan
2
Ifosfamide
2
Carboplatin
2
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
talazoparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Counseling
×
30 days
×
Clear all
No trials found.